OPKO HEALTH INC
For the period ended Dec 31, 2024. Filed Mar 3, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Mar 3, 2025
OPK$1.71-1.2%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Operations
| For the years ended December 31, | |||
|---|---|---|---|
| 2024 | 2023 | 2022 | |
| Revenues: | |||
| Revenue from services | $480,667 | $515,275 | $755,630 |
| Revenue from products | 155,111 | 167,557 | 142,845 |
| Revenue from transfer of intellectual property and other | 77,364 | 180,663 | 105,721 |
| Total revenues | 713,142 | 863,495 | 1,004,196 |
| Costs and expenses: | |||
| Cost of service revenue | 402,109 | 445,830 | 627,548 |
| Cost of product revenue | 92,523 | 99,538 | 88,429 |
| Selling, general and administrative | 304,220 | 300,559 | 372,672 |
| Research and development | 105,214 | 89,593 | 73,887 |
| Contingent consideration | — | (1,036) | (1,312) |
| Amortization of intangible assets | 82,634 | 86,032 | 87,784 |
| Gain on sale of assets | (121,493) | — | (18,559) |
| Total costs and expenses | 865,207 | 1,020,516 | 1,230,449 |
| Operating loss | (152,065) | (157,021) | (226,253) |
| Other income and (expense), net: | |||
| Interest income | 8,426 | 3,983 | 1,981 |
| Interest expense | (47,465) | (13,506) | (12,056) |
| Fair value changes of derivative instruments, net | (26,161) | (781) | 649 |
| Other income (expense), net | 206,903 | (16,994) | (155,842) |
| Other income (expense), net | 141,703 | (27,298) | (165,268) |
| Loss before income taxes and investment losses | (10,362) | (184,319) | (391,521) |
| Income tax (provision) benefit | (42,844) | (4,437) | 63,499 |
| Net loss before investment losses | (53,206) | (188,756) | (328,022) |
| Loss from investments in investees | (18) | (107) | (383) |
| Net loss | $(53,224) | $(188,863) | $(328,405) |
| Loss per share basic and diluted: | |||
| Loss per share | $(0.08) | $(0.25) | $(0.46) |
| Weighted average number of common shares outstanding, basic and diluted | 694,019,535 | 751,765,915 | 719,060,942 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.